Suchergebnisse - (Person:"Bojkova, Denisa")

PubPharm (111)

41

Omicron-induced interferon signalling prevents influenza A virus infection

enthalten in: bioRxiv.org | 2022

von Bojkova, D. | Bechtel, M. | Rothenburger, T. | +9

42

USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING

enthalten in: Cell death & disease | 2022

von Karlowitz, R. | Stanifer, M. | Roedig, J. | +10

43

Inhibition of papain-like protease PLpro blocks SARS-CoV-2 spread and promotes anti-viral immunity

enthalten in: ResearchSquare.com | 2022

von Shin, D. | Mukherjee, R. | Grewe, D. | +17

44

SARS-CoV-2 infected host cell proteomics reveal potential therapy targets

enthalten in: ResearchSquare.com | 2022

von Bojkova, D. | Klann, K. | Koch, B. | +5

45

Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform

enthalten in: bioRxiv.org | 2022

von Bojkova, D. | Reus, P. | Panosch, L. | +22

46

Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity : Evaluation of 5676 Phase 1 Passed Structures

enthalten in: Journal of medical virology | 2022

von Chiu, W. | Verschueren, L. | Van den Eynde, C. | +11

47

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates

enthalten in: bioRxiv.org | 2022

von Bojkova, D. | Widera, M. | Ciesek, S. | +3

48

Development and optimisation of a high-throughput screening assay for in vitro anti–SARS-CoV-2 activity: evaluation of 5676 phase 1 passed structures

enthalten in: bioRxiv.org | 2022

von Chiu, W. | Verschueren, L. | Van den Eynde, C. | +11

49

SARS-CoV-2 screening strategies for returning international travellers : Evaluation of a rapid antigen test approach

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Layer, E. | Hoehl, S. | Widera, M. | +7

50

SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment

enthalten in: Cell discovery | 2022

von Bojkova, D. | Rothenburger, T. | Ciesek, S. | +3